BRIGHT MINDS BIOSCIENCES INC.
Develops selective serotonin agonists for neurological and psychiatric disorders.
DRUG | US
Overview
Corporate Details
- ISIN(s):
- CA10919W1086
- LEI:
- Country:
- United States of America
- Address:
- 19 VESTRY STREET, 10013 NEW YORK
- Website:
- https://brightmindsbio.com/
- Sector:
- Manufacturing
Description
Bright Minds Biosciences Inc. is a biotechnology company developing novel treatments for neurological and psychiatric disorders. The company's approach focuses on healing the central nervous system and brain through the regulation of serotonin. Using a proprietary chemistry platform, Bright Minds develops highly selective serotonin receptor agonists, specifically targeting 5-HT2A and 5-HT2C receptors while avoiding 5-HT2B activity to improve the safety profile of its drug candidates. Its therapeutic pipeline addresses conditions such as epilepsy, neuropsychiatric disorders, and pain, with dedicated programs for rare diseases like Prader-Willi Syndrome.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BRIGHT MINDS BIOSCIENCES INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRIGHT MINDS BIOSCIENCES INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRIGHT MINDS BIOSCIENCES INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
